000			01591nam a22001697a 4500
999			_c259204 _d259204
003			0
005			20200527094334.0
020			_a9789353450441
082			_a621.1 _bEBA
100			_aEban, Katherine
245			_aBottles of lies : Ranbaxy and the dark side of Indian pharma
260			_aNew Delhi _bJuggernaut Books _c2019
300			_a482
500			_aIn 2004, Dinesh Thakur, a senior employee of Ranbaxy, then India’s largest pharma company, discovered a terrible secret.Ranbaxy had been fabricating the test results of their drugs,endangering millions of patients. Thakur resigned and became a whistleblower to the US Food and Drug Administration, one of the regulators Ranbaxy had been lying to, and ultimately brought the multibillion-dollar behemoth to its knees. This is the sensational account of the high-stakes chase to bring Ranbaxy to book and the fall from grace of one of corporate India’s biggest success stories. But the rot in Indian pharma isn’t confined to Ranbaxy alone. In this book, investigative journalist Katherine Eban relies on over 20,000 FDA documents and interviews with over 240 people to show how fraud and trickery are deeply entrenched in much of the industry in India, and raises troubling questions about some of its biggest names – Wockhardt, Dr Reddy’s, Glenmark and RPG Life Sciences. Filled with shocking and eye-opening details, this book lays bare the ugly truth of Indian pharma. It will make you view every pill you take with foreboding and suspicion.
650			_aPharmaceutical industry - Corrupt practices - India
942			_cB